BLOOD-dose

BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases.

Teclistamab OR talquetamab OR elranatamab OR linvoseltamabOngoingNot yet recruitingPhase 4Open NCT07474961 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…